Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15894659 | 1.00 | CYP1A2 (0.41) | CYP1A2CYP2C19KMT2AOPRL1ADRA2A | |
| SCHEMBL23364949 | 1.00 | CYP1A2 (0.41) | CYP1A2CYP2C19KMT2AOPRL1ADRA2A | |
| SCHEMBL23364947 | 0.90 | CYP1A2 (0.39) | CYP1A2CYP2C19KMT2AOPRL1ADRA2A | |
| SCHEMBL15894663 | 0.90 | CYP1A2 (0.39) | CYP1A2CYP2C19KMT2AOPRL1ADRA2A | |
| SCHEMBL15894671 | 0.84 | CYP2C19 (0.41) | CYP1A2CYP2C19KMT2AOPRL1ADRA2A | |
| SCHEMBL15891606 | 0.84 | OPRL1 (0.34) | CYP1A2CYP2C19KMT2AOPRL1F2 | |
| SCHEMBL28955152 | 0.82 | OPRL1 (0.33) | OPRL1ADRA2AADRA2BADRA2CF2 | |
| SCHEMBL22743930 | 0.79 | OPRL1 (0.46) | CYP1A2CYP2C19KMT2AOPRL1KCNH2 | |
| SCHEMBL30656312 | 0.79 | OPRL1 (0.46) | CYP1A2CYP2C19KMT2AOPRL1KCNH2 | |
| SCHEMBL26836231 | 0.76 | OPRL1 (0.34) | CYP1A2CYP2C19KMT2AOPRL1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028363-A1 | CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL | RECURIUM IP HOLDINGS LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12410204-B2 | Chiral synthesis of a tertiary alcohol | RECURIUM IP HOLDINGS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20230002426-A1 | CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL | RECURIUM IP HOLDINGS, LLC | 2023-01-05 | — | — | US | disclosed |
| EP-4045486-A1 | CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL | Recurium IP Holdings, LLC (US) | 2022-08-24 | — | — | EP | disclosed |
| WO-2021097139-A1 | CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL | RECURIUM IP HOLDINGS, LLC (US) | 2021-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410204-B2 | Chiral synthesis of a tertiary alcohol | ADH1A, ADH1C, ADH5 | CYP1A2 102/4885CYP2C19 919/4885KMT2A 3070/4885 |
| US-20260028363-A1 | CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL | ADH1A, ADH1C, ADH5 | CYP1A2 193/4885CYP2C19 544/4885KMT2A 2872/4885 |
| US-20230002426-A1 | CHIRAL SYNTHESIS OF A TERTIARY ALCOHOL | ADH1A, ADH1C, ADH5 | CYP1A2 102/4885CYP2C19 919/4885KMT2A 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.